Related references
Note: Only part of the references are listed.Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults
Richard D. Semba et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
Metabolic Responses to Reductive Stress
Wusheng Xiao et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
An engineered enzyme that targets circulating lactate to alleviate intracellular NADH:NAD+ imbalance
Anupam Patgiri et al.
NATURE BIOTECHNOLOGY (2020)
Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell
Eran Mick et al.
ELIFE (2020)
Hepatic NADH reductive stress underlies common variation in metabolic traits
Russell P. Goodman et al.
NATURE (2020)
Mitochondrial diseases in North America: An analysis of the NAMDC Registry
Emanuele Barca et al.
NEUROLOGY-GENETICS (2020)
A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS)
Karien Esterhuizen et al.
MITOCHONDRION (2019)
The Effect of 2-Ketobutyrate on Mitochondrial Substrate-Level Phosphorylation
David Bui et al.
NEUROCHEMICAL RESEARCH (2019)
Exploring mTOR inhibition as treatment for mitochondrial disease
Abigail Sage-Schwaede et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review
Chaofu Ke et al.
METABOLOMICS (2019)
A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway
Yue-Li Sun et al.
BMC CANCER (2019)
HMDB 4.0: the human metabolome database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Plasma proteomic signature of age in healthy humans
Toshiko Tanaka et al.
AGING CELL (2018)
The urinary organic acids profile in single large-scale mitochondrial DNA deletion disorders
Michela Semeraro et al.
CLINICA CHIMICA ACTA (2018)
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
John P. Grady et al.
EMBO MOLECULAR MEDICINE (2018)
Emerging therapies for mitochondrial diseases
Michio Hirano et al.
MITOCHONDRIAL DISEASES (2018)
HS6ST1 Insufficiency Causes Self-Limited Delayed Puberty in Contrast With Other GnRH Deficiency Genes
Sasha R. Howard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)
German Reyes-Botero et al.
ONCOLOGIST (2018)
Mitochondrial DNA m.3243A > G heteroplasmy affects multiple aging phenotypes and risk of mortality
Gregory J. Tranah et al.
SCIENTIFIC REPORTS (2018)
Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers
Jana Buzkova et al.
EMBO MOLECULAR MEDICINE (2018)
Prediction of long-term prognosis by heteroplasmy levels of the m.3243A>G mutation in patients with the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome
A. Fayssoil et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
Hyo Kyun Chung et al.
JOURNAL OF CELL BIOLOGY (2017)
Mitochondrial disease and endocrine dysfunction
Jasmine Chow et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Elevated α-Hydroxybutyrate and Branched-Chain Amino Acid Levels Predict Deterioration of Glycemic Control in Adolescents
Domenico Trico et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
Shannon E. Mullican et al.
NATURE MEDICINE (2017)
Cause of Death in Children With Mitochondrial Diseases
Soyong Eom et al.
PEDIATRIC NEUROLOGY (2017)
Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy
Nigel F. Delaney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Monitoring clinical progression with mitochondrial disease biomarkers
Hannah E. Steele et al.
BRAIN (2017)
GDF15 is a heart-derived hormone that regulates body growth
Ting Wang et al.
EMBO MOLECULAR MEDICINE (2017)
The use of the soluble adhesion molecules sE-selectin, sICAM-1, sVCAM-1, sPECAM-1 and their ligands CD11a and CD49d as diagnostic and prognostic biomarkers in septic and critically ill non-septic ICU patients
Anders G. Kjaergaard et al.
APMIS (2016)
Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options
Robert H. Fryer et al.
PEDIATRIC NEUROLOGY (2016)
Hypoxia as a therapy for mitochondrial disease
Isha H. Jain et al.
SCIENCE (2016)
GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction
Raquel Montero et al.
PLOS ONE (2016)
Prevalence of Nuclear and Mitochondrial DNA Mutations Related to Adult Mitochondrial Disease
Grainne S. Gorman et al.
ANNALS OF NEUROLOGY (2015)
Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders
Shuichi Yatsuga et al.
ANNALS OF NEUROLOGY (2015)
Whole exome sequencing of suspected mitochondrial patients in clinical practice
Saskia B. Wortmann et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases
Yasunori Fujita et al.
MITOCHONDRION (2015)
N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids
Robert S. Jansen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A Metabolic Signature of Mitochondrial Dysfunction Revealed through a Monogenic Form of Leigh Syndrome
Julie Thompson Legault et al.
CELL REPORTS (2015)
Quantitative H2S-mediated protein sulfhydration reveals metabolic reprogramming during the integrated stress response
Xing-Huang Gao et al.
ELIFE (2015)
Efficacy of pyruvate therapy in patients with mitochondrial disease: A semi-quantitative clinical evaluation study
Tatsuya Fujii et al.
MOLECULAR GENETICS AND METABOLISM (2014)
A multicenter study on Leigh syndrome: disease course and predictors of survival
Kalliopi Sofou et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Powering the Immune System: Mitochondria in Immune Function and Deficiency
Melissa A. Walker et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Predisposition to infection and SIRS in mitochondrial disorders: 8 years' experience in an academic center
Melissa A. Walker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT
Stephen A. Varvel et al.
BMJ OPEN DIABETES RESEARCH & CARE (2014)
MELAS: A nationwide prospective cohort study of 96 patients in Japan
Shuichi Yatsuga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Proteomic and Metabolomic Analyses of Mitochondrial Complex I-deficient Mouse Model Generated by Spontaneous B2 Short Interspersed Nuclear Element (SINE) Insertion into NADH Dehydrogenase (Ubiquinone) Fe-S Protein 4 (Ndufs4) Gene
Dillon W. Leong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation
Paul de Laat et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation
Ayman W. El-Hattab et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Biomarkers for mitochondrial respiratory chain disorders
Anu Suomalainen
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype
P. Kaufmann et al.
NEUROLOGY (2011)
Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism
Janne Tornberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
Walter E. Gall et al.
PLOS ONE (2010)
A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells
Oded Shaham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Longitudinal Changes of mtDNA A3243G Mutation Load and Level of Functioning in MELAS
Mahsa Mehrazin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation
Petra Kaufmann et al.
ARCHIVES OF NEUROLOGY (2009)
Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells
Christian M. Metallo et al.
JOURNAL OF BIOTECHNOLOGY (2009)
URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE m.3243A>G mtDNA MUTATION
R. G. Whittaker et al.
NEUROLOGY (2009)
Pathogenic mitochondrial DNA mutations are common in the general population
Hannah R. Elliott et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Population prevalence of the MELAS A3243G mutation
Neil Manwaring et al.
MITOCHONDRION (2007)
Mitochondrial disease criteria - Diagnostic applications in children
E. Morava et al.
NEUROLOGY (2006)
Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production
A Trifunovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
GC Kujoth et al.
SCIENCE (2005)
Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: Identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics
X Su et al.
BIOCHEMISTRY (2005)
L-arginine improves the symptoms of stroke-like episodes in MELAS
Y Koga et al.
NEUROLOGY (2005)
Cerebral lactic acidosis correlates with neurological impairment in MELAS
P Kaufmann et al.
NEUROLOGY (2004)
Minimum birth prevalence of mitochondrial respiratory chain disorders in children
D Skladal et al.
BRAIN (2003)
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:: Potential role of PGC1 and NRF1
ME Patti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Diagnostic criteria for respiratory chain disorders in adults and children
FP Bernier et al.
NEUROLOGY (2002)
The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection
JL Edmonds et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2002)
Decrease of 3243 A -> G mtDNA mutation from blood in MELAS syndrome: A longitudinal study
S Rahman et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
